Eliminating drugs from the body is a vital process that occurs through excretion or metabolism. Understanding the kinetics of drug elimination is crucial for drug development, dosage determination, and optimizing patient outcomes.

Drug clearance depends on the rate of drug elimination and its plasma concentration. Another important parameter is the half-life of a drug, which is the time required for its concentration to decrease by half. In most cases, drug clearance follows first-order kinetics, where a constant fraction of the drug is eliminated per unit time. This means that as the drug concentration increases, its elimination rate also increases. The relationship between drug concentration and time is exponential.

However, certain drugs, like phenytoin and aspirin, exhibit zero-order kinetics. When administered at high therapeutic doses, these drugs saturate the enzymes responsible for their metabolism. As a result, only a fixed amount of the drug is eliminated at a constant rate, regardless of its concentration. The plot of drug concentration versus time in zero-order kinetics is linear, indicating that increasing the drug concentration does not affect its elimination rate.

Tags
Drug EliminationKineticsDrug ClearancePlasma ConcentrationHalf lifeFirst order KineticsZero order KineticsPhenytoinAspirinMetabolismExcretionDosage DeterminationPatient Outcomes

Du chapitre 3:

article

Now Playing

3.24 : Kinetics of Drug Elimination

Pharmacokinetics

2.9K Vues

article

3.1 : Pharmacocinétique : Vue d’ensemble

Pharmacokinetics

3.4K Vues

article

3.2 : Mécanisme d’absorption du médicament : transport membranaire passif

Pharmacokinetics

3.0K Vues

article

3.3 : Mécanisme d’absorption du médicament : transport membranaire médié par le transporteur

Pharmacokinetics

3.0K Vues

article

3.4 : Absorption des médicaments : facteurs affectant l’absorption gastro-intestinale

Pharmacokinetics

3.3K Vues

article

3.5 : Biodisponibilité : Vue d’ensemble

Pharmacokinetics

2.1K Vues

article

3.6 : Facteurs influençant la biodisponibilité : élimination au premier passage

Pharmacokinetics

5.5K Vues

article

3.7 : Bioéquivalence : Vue d’ensemble

Pharmacokinetics

752 Vues

article

3.8 : Effet de premier passage

Pharmacokinetics

4.4K Vues

article

3.9 : Évolution temporelle de l’effet du médicament

Pharmacokinetics

1.7K Vues

article

3.10 : Distribution du médicament : liaison tissulaire

Pharmacokinetics

2.2K Vues

article

3.11 : Barrières physiologiques

Pharmacokinetics

3.1K Vues

article

3.12 : Distribution du médicament : liaison aux protéines plasmatiques

Pharmacokinetics

3.1K Vues

article

3.13 : Modèles à compartiments : Modèle à compartiment unique

Pharmacokinetics

1.8K Vues

article

3.14 : Modèles à compartiments : Modèle à deux compartiments

Pharmacokinetics

4.6K Vues

See More

JoVE Logo

Confidentialité

Conditions d'utilisation

Politiques

Recherche

Enseignement

À PROPOS DE JoVE

Copyright © 2025 MyJoVE Corporation. Tous droits réservés.